June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Diego Díaz García Highlights LAG-3 as Emerging Checkpoint Target in Melanoma
Jun 9, 2025, 07:29

Diego Díaz García Highlights LAG-3 as Emerging Checkpoint Target in Melanoma

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, posted on X:

“Emerging checkpoint target: LAG-3.
Combining relatlimab (anti–LAG-3) with nivolumab enhances efficacy in melanoma vs. PD-1 alone, potentially with less toxicity than CTLA-4 combos. New frontiers in solid tumors are opening.”

Title: The emerging role of lymphocyte-activation gene 3 targeting in the treatment of solid malignancies

Authors: Vinay K. Giri, David F. McDermott, Jacob Zaemes

Read The Full Article at ACS Journal.

Diego Díaz García Highlights LAG-3 as Emerging Checkpoint Target in Melanoma

More posts featuring Diego Díaz García.